Doxazosin Tablet
Product Images NDC 70518-4031

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 70518-4031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a prescription medication in tablet form. The dosage is 4 mg. The quantity is 90 tablets. It is manufactured by Apotex Corp., located in Weston, FL. The medication should be stored at 20-25°C (58-77°F) with excursions permitted to 15.30°C (59-86°F). The lot number, expiration date, and instructions for use are not available in the provided text.*

FDA Label Image

Doxazosin-structure.jpg (Doxazosin Structure)

FDA Label Image

Figure1.jpg (Figure1)

Mean Change in Total Symptom Score from Baseline and Mean Increase in Maximum Urinary Flow Rate (mL/sec) from Baseline were evaluated over a duration of treatment in weeks. The data suggests a significant improvement from baseline compared to both placebo and baseline. Doxazosin titration to a maximum of 8 mg was also part of the study.*

FDA Label Image

Table3.jpg (Table3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.